Champions Oncology (CSBR) Cash from Investing Activities (2016 - 2025)
Historic Cash from Investing Activities for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to -$242000.0.
- Champions Oncology's Cash from Investing Activities fell 15744.68% to -$242000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$583000.0, marking a year-over-year decrease of 21857.92%. This contributed to the annual value of -$389000.0 for FY2025, which is 5346.89% up from last year.
- Latest data reveals that Champions Oncology reported Cash from Investing Activities of -$242000.0 as of Q4 2025, which was down 15744.68% from -$46000.0 recorded in Q3 2025.
- Champions Oncology's 5-year Cash from Investing Activities high stood at $3000.0 for Q2 2024, and its period low was -$1.2 million during Q1 2021.
- Over the past 5 years, Champions Oncology's median Cash from Investing Activities value was -$506000.0 (recorded in 2022), while the average stood at -$463473.7.
- In the last 5 years, Champions Oncology's Cash from Investing Activities soared by 10039.47% in 2024 and then plummeted by 853333.33% in 2025.
- Quarter analysis of 5 years shows Champions Oncology's Cash from Investing Activities stood at -$566000.0 in 2021, then fell by 6.71% to -$604000.0 in 2022, then soared by 86.92% to -$79000.0 in 2023, then fell by 18.99% to -$94000.0 in 2024, then plummeted by 157.45% to -$242000.0 in 2025.
- Its Cash from Investing Activities was -$242000.0 in Q4 2025, compared to -$46000.0 in Q3 2025 and -$253000.0 in Q2 2025.